|
| 瑞普生物(300119)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-06-02 | 122.82 | 0.26% | 33621.05 | 12963.74 | 33498.23 | 71.91% | 股权激励限售股份 | | 2024-06-19 | 71.96 | 0.15% | 33498.23 | 13129.39 | 33426.27 | 71.69% | 股权激励限售股份 | | 2022-06-27 | 130.00 | 0.28% | 31712.08 | 15101.20 | 31712.08 | 67.74% | 股权激励限售股份 | | 2022-05-19 | 6398.47 | 13.66% | 31992.73 | 14841.67 | 31992.73 | 68.31% | 定向增发机构配售股份 | | 2022-01-10 | 148.97 | 0.32% | 25366.10 | 21468.30 | 25366.10 | 54.16% | 股权激励限售股份 | | 2020-07-01 | 211.77 | 0.52% | 40122.02 | 327.33 | 40449.35 | 100.00% | 股权激励限售流通 | | 2019-08-23 | 1534.72 | 3.79% | 39910.25 | 539.10 | 40449.35 | 100.00% | 增发A股法人配售上市 | | 2013-09-17 | 8324.68 | 42.92% | 19394.65 | 0.00 | 19394.65 | 100.00% | 发行前股份限售流通 | | 2011-09-19 | 4706.00 | 31.73% | 8426.00 | 6403.60 | 14829.60 | 100.00% | 发行前股份限售流通 | | 2010-12-17 | 372.00 | 5.02% | 1860.00 | 5554.80 | 7414.80 | 100.00% | A股发行法人配售上市 |
|